Metraipolis › archive › dc_d40e7f29febc

Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation — Europe PMC PPR:PPR1286973

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR1286973
DOI
10.21203/rs.3.rs-9656350/v1
License (as archived)
solo-consultazione
Archived
2026-10-17T14:13:23.998Z
SHA-256 of the archived text
88468f1db9ad65d0dd401ed702260a417abbb50e2a112aa18814eee277c332c0
Stable URL of this page
https://metraipolis.com/documento/dc_d40e7f29febc

How to cite

Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation — Europe PMC PPR:PPR1286973 — Europe PMC, https://europepmc.org/article/PPR/PPR1286973 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d40e7f29febc (Metraipolis archive dc_d40e7f29febc, sha256 88468f1db9ad65d0dd401ed702260a417abbb50e2a112aa18814eee277c332c0)
BibTeX
@misc{dcd40e7f29febc,
  title = {Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation — Europe PMC PPR:PPR1286973},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR1286973},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d40e7f29febc; sha256 88468f1db9ad65d0dd401ed702260a417abbb50e2a112aa18814eee277c332c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1286973. Agents can read the archived copy with the MCP tool read_document.